JANX

Janux Therapeutics, Inc.CIK 1817713 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for JANX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for JANX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Campbell David Alan	President and CEO, Director	22	$0	$6.61M	2026-07-31
Simson Jake	Director	9	$0	$0	2026-06-11
RA Capital Nexus Fund II, L.P.	Director	5	$12.44M	$0	2026-06-11
Hernday Natasha	Director	10	$0	$0	2026-06-11
Kung Winston	Director	9	$0	$0	2026-06-11
Barrett Ronald W	Director	9	$0	$0	2026-06-11
CAPPS VICKIE L	Director	10	$0	$0	2026-06-11
DOBMEIER ERIC	Director	10	$0	$0	2026-06-11
Doyle Janeen Noel	Chief Corp. & Bus. Dev. Ofcr	5	$0	$56.9K	2026-06-02
Dobek Maria	Vice President, Accounting	6	$0	$49.0K	2026-05-11
Go William	Chief Medical Officer	2	$0	$0	2026-02-02
McIver Zachariah	Chief Medical Officer	5	$0	$37.3K	2026-01-02
DiRaimondo Thomas	Chief Scientific Officer	8	$0	$266.1K	2026-01-02
Winter Charles M.	Chief Technical Officer	7	$0	$33.0K	2026-01-02
Meyer Andrew Hollman	Chief Business Officer	46	$0	$4.22M	2026-01-02
McNulty Alana B.	Director	7	$0	$0	2025-06-11
Gujrathi Sheila	Director	8	$0	$0	2025-06-11
RA Capital Healthcare Fund LP	Director, 10% Owner	7	$90.34M	$0	2025-06-11
Robinson Byron	Chief Strategy Officer	5	$0	$0	2025-01-02
Avalon BioVentures SPV I, L.P.	10% Owner	33	$0	$77.47M	2024-10-18
Kolchinsky Peter	Director, 10% Owner	2	$53.70M	$0	2024-10-18
Avalon BioVentures I, LP	10% Owner	51	$0	$45.78M	2024-09-30
Lichter Jay	Director, 10% Owner	29	$15.69M	$82.30M	2024-09-13
RA CAPITAL MANAGEMENT, L.P.	Director, 10% Owner	12	$50.00M	$0	2024-06-26
Reardon Tighe	Acting Chief Financial Officer	11	$15.69M	$45.04M	2024-06-03
Avalon Ventures XI, L.P.	10% Owner	24	$15.69M	$82.13M	2024-06-03
Godfrey Wayne	Chief Medical Officer	2	$0	$0	2023-01-03
Heller Stefan	Director	1	$0	$0	2022-06-14
Thompson Peter A.	Director, 10% Owner	16	$12.00M	$10.59M	2022-06-14
Salek-Ardakani Shahram	Chief Scientific Officer	1	$0	$0	2022-01-03
OrbiMed Genesis GP LLC	Director	6	$0	$10.59M	2021-12-29
Bregua Corp	10% Owner	9	$1000.0K	$0	2021-06-15
ORBIMED ADVISORS LLC	Director	8	$12.00M	$0	2021-06-15

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Campbell David Alan	President and CEO	G Gift	2026-07-31	2026-07-31	123,840	—	$0	264,742	SEC↗
Campbell David Alan	President and CEO, Director	G Gift	2026-07-31	2026-07-31	123,840	—	$0	264,742	SEC↗
Campbell David Alan	President and CEO	M Exercise deriv	2026-07-08	2026-07-10	7,000	—	$0	697,550	SEC↗
Campbell David Alan	President and CEO	M Exercise	2026-07-08	2026-07-10	7,000	$4.21	$29.5K	388,582	SEC↗
Barrett Ronald W	Director	A Award deriv	2026-06-11	2026-06-12	15,500	—	$0	15,500	SEC↗
CAPPS VICKIE L	Director	A Award deriv	2026-06-11	2026-06-12	15,500	—	$0	15,500	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2026-06-11	2026-06-12	15,500	—	$0	15,500	SEC↗
Hernday Natasha	Director	A Award deriv	2026-06-11	2026-06-12	15,500	—	$0	15,500	SEC↗
Kung Winston	Director	A Award deriv	2026-06-11	2026-06-12	15,500	—	$0	15,500	SEC↗
Simson Jake	Director	A Award deriv	2026-06-11	2026-06-12	15,500	—	$0	15,500	SEC↗
RA Capital Nexus Fund II, L.P.	Director	A Award deriv	2026-06-11	2026-06-12	15,500	—	$0	15,500	SEC↗
Barrett Ronald W	Director	A Award	2026-06-11	2026-06-12	5,500	—	$0	11,750	SEC↗
CAPPS VICKIE L	Director	A Award	2026-06-11	2026-06-12	5,500	—	$0	79,598	SEC↗
DOBMEIER ERIC	Director	A Award	2026-06-11	2026-06-12	5,500	—	$0	15,481	SEC↗
Hernday Natasha	Director	A Award	2026-06-11	2026-06-12	5,500	—	$0	15,481	SEC↗
Kung Winston	Director	A Award	2026-06-11	2026-06-12	5,500	—	$0	11,750	SEC↗
Simson Jake	Director	A Award	2026-06-11	2026-06-12	5,500	—	$0	11,750	SEC↗
RA Capital Nexus Fund II, L.P.	Director	A Award	2026-06-11	2026-06-12	5,500	—	$0	11,750	SEC↗
Doyle Janeen Noel	Chief Corp. & Bus. Dev. Ofcr	S Sale	2026-06-02	2026-06-04	4,059	$14.03	$56.9K	75,941	SEC↗
Dobek Maria	Vice President, Accounting	S Sale	2026-05-11	2026-05-13	2,038	$14.17	$28.9K	32,270	SEC↗
Go William	Chief Medical Officer	A Award deriv	2026-02-02	2026-02-04	154,000	—	$0	154,000	SEC↗
Go William	Chief Medical Officer	A Award	2026-02-02	2026-02-04	44,000	—	$0	44,000	SEC↗
Dobek Maria	Vice President, Accounting	A Award deriv	2026-01-02	2026-01-02	42,600	—	$0	42,600	SEC↗
Doyle Janeen Noel	Chief Corp. & Bus. Dev. Ofcr	A Award deriv	2026-01-02	2026-01-02	126,000	—	$0	126,000	SEC↗
McIver Zachariah	Chief Medical Officer	A Award deriv	2026-01-02	2026-01-02	101,500	—	$0	101,500	SEC↗
Winter Charles M.	Chief Technical Officer	A Award deriv	2026-01-02	2026-01-02	100,100	—	$0	100,100	SEC↗
Campbell David Alan	President and CEO	A Award deriv	2026-01-02	2026-01-02	338,100	—	$0	338,100	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	A Award deriv	2026-01-02	2026-01-02	109,900	—	$0	109,900	SEC↗
Dobek Maria	Vice President, Accounting	S Sale	2026-01-02	2026-01-02	1,462	$13.73	$20.1K	15,373	SEC↗
Dobek Maria	Vice President, Accounting	A Award	2026-01-02	2026-01-02	18,935	—	$0	34,308	SEC↗
Doyle Janeen Noel	Chief Corp. & Bus. Dev. Ofcr	A Award	2026-01-02	2026-01-02	36,000	—	$0	80,000	SEC↗
McIver Zachariah	Chief Medical Officer	S Sale	2026-01-02	2026-01-02	2,714	$13.73	$37.3K	23,286	SEC↗
McIver Zachariah	Chief Medical Officer	A Award	2026-01-02	2026-01-02	29,000	—	$0	52,286	SEC↗
Winter Charles M.	Chief Technical Officer	S Sale	2026-01-02	2026-01-02	2,401	$13.73	$33.0K	77,721	SEC↗
Winter Charles M.	Chief Technical Officer	A Award	2026-01-02	2026-01-02	28,600	—	$0	106,321	SEC↗
Campbell David Alan	President and CEO	S Sale	2026-01-02	2026-01-02	8,072	$13.73	$110.8K	284,982	SEC↗
Campbell David Alan	President and CEO	A Award	2026-01-02	2026-01-02	96,600	—	$0	381,582	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	A Award	2026-01-02	2026-01-02	31,400	—	$0	155,825	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	S Sale	2026-01-02	2026-01-02	2,505	$13.73	$34.4K	124,425	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2026-01-02	2026-01-02	1,879	$13.73	$25.8K	83,095	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-12-01	2025-12-03	3,333	—	$0	114,768	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-12-01	2025-12-03	3,333	$10.59	$35.3K	88,307	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-12-01	2025-12-03	2,700	$32.85	$88.7K	85,607	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-12-01	2025-12-03	633	$33.52	$21.2K	84,974	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-11-14	2025-11-14	3,333	—	$0	118,101	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-11-14	2025-11-14	3,333	$10.59	$35.3K	88,307	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-11-14	2025-11-14	3,333	$30.00	$100.0K	84,974	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-10-28	2025-10-30	9,999	—	$0	77,333	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-10-28	2025-10-30	6,666	—	$0	121,434	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-10-28	2025-10-30	6,666	$10.59	$70.6K	98,804	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-10-28	2025-10-30	9,999	$4.21	$42.1K	92,138	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-10-28	2025-10-30	16,665	$30.06	$500.9K	82,139	SEC↗
Kung Winston	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
Simson Jake	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
McNulty Alana B.	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
Hernday Natasha	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
Gujrathi Sheila	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
CAPPS VICKIE L	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
Barrett Ronald W	Director	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	A Award deriv	2025-06-11	2025-06-13	11,667	—	$0	11,667	SEC↗
Kung Winston	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	6,250	SEC↗
Simson Jake	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	6,250	SEC↗
McNulty Alana B.	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	6,250	SEC↗
Hernday Natasha	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	8,731	SEC↗
Gujrathi Sheila	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	118,889	SEC↗
DOBMEIER ERIC	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	9,981	SEC↗
CAPPS VICKIE L	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	74,098	SEC↗
Barrett Ronald W	Director	A Award	2025-06-11	2025-06-13	3,750	—	$0	6,250	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	A Award	2025-06-11	2025-06-13	3,750	—	$0	6,250	SEC↗
Doyle Janeen Noel	Chief Corp. & Bus. Dev. Ofcr	A Award deriv	2025-06-02	2025-06-04	154,000	—	$0	154,000	SEC↗
Doyle Janeen Noel	Chief Corp. & Bus. Dev. Ofcr	A Award	2025-06-02	2025-06-04	44,000	—	$0	44,000	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-05-01	2025-05-02	3,333	—	$0	87,332	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-05-01	2025-05-02	3,333	$4.21	$14.0K	85,472	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-05-01	2025-05-02	2,933	$31.95	$93.7K	82,539	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-05-01	2025-05-02	400	$32.60	$13.0K	82,139	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-04-21	2025-04-23	3,334	—	$0	90,665	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-04-21	2025-04-23	3,334	$4.21	$14.0K	85,473	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-04-21	2025-04-23	3,334	$30.00	$100.0K	82,139	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy	2025-03-07	2025-03-07	110,206	$31.02	$3.42M	10,141,287	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy	2025-03-06	2025-03-07	372,093	$30.78	$11.45M	10,031,081	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy	2025-03-05	2025-03-07	37,455	$31.30	$1.17M	9,658,988	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy	2025-03-05	2025-03-07	304,287	$30.56	$9.30M	9,621,533	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-03-03	2025-03-05	3,334	—	$0	93,999	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-03-03	2025-03-05	2,433	$31.88	$77.6K	83,040	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-03-03	2025-03-05	901	$32.85	$29.6K	82,139	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-03-03	2025-03-05	3,334	$4.21	$14.0K	85,473	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2025-02-03	2025-02-05	3,334	—	$0	97,333	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2025-02-03	2025-02-05	3,334	$4.21	$14.0K	85,473	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-02-03	2025-02-05	2,418	$42.08	$101.7K	83,055	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-02-03	2025-02-05	816	$42.77	$34.9K	82,239	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-02-03	2025-02-05	100	$43.60	$4.4K	82,139	SEC↗
Campbell David Alan	President and CEO	S Sale	2025-01-07	2025-01-08	5,000	$60.00	$300.0K	293,054	SEC↗
Meyer Andrew Hollman	Chief Business Officer	A Award deriv	2025-01-02	2025-01-03	63,000	—	$0	63,000	SEC↗
Dobek Maria	Vice President, Accounting	A Award deriv	2025-01-02	2025-01-03	31,500	—	$0	31,500	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	A Award deriv	2025-01-02	2025-01-03	84,000	—	$0	84,000	SEC↗
Robinson Byron	Chief Strategy Officer	A Award deriv	2025-01-02	2025-01-03	98,000	—	$0	98,000	SEC↗
Campbell David Alan	President and CEO	A Award deriv	2025-01-02	2025-01-03	283,500	—	$0	283,500	SEC↗
Winter Charles M.	Chief Technical Officer	A Award deriv	2025-01-02	2025-01-03	80,500	—	$0	80,500	SEC↗
McIver Zachariah	Chief Medical Officer	A Award deriv	2025-01-02	2025-01-03	91,000	—	$0	91,000	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-01-02	2025-01-03	200	$57.37	$11.5K	82,139	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-01-02	2025-01-03	3,444	$55.76	$192.0K	83,339	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-01-02	2025-01-03	1,000	$56.78	$56.8K	82,339	SEC↗
Meyer Andrew Hollman	Chief Business Officer	A Award	2025-01-02	2025-01-03	18,000	—	$0	95,473	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-01-02	2025-01-03	2,922	$53.76	$157.1K	92,551	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2025-01-02	2025-01-03	5,768	$54.51	$314.4K	86,783	SEC↗
Dobek Maria	Vice President, Accounting	A Award	2025-01-02	2025-01-03	14,000	—	$0	14,001	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	A Award	2025-01-02	2025-01-03	24,000	—	$0	129,719	SEC↗
Robinson Byron	Chief Strategy Officer	A Award	2025-01-02	2025-01-03	28,000	—	$0	28,000	SEC↗
Campbell David Alan	President and CEO	A Award	2025-01-02	2025-01-03	81,000	—	$0	298,054	SEC↗
Winter Charles M.	Chief Technical Officer	A Award	2025-01-02	2025-01-03	23,000	—	$0	77,288	SEC↗
McIver Zachariah	Chief Medical Officer	A Award	2025-01-02	2025-01-03	26,000	—	$0	26,000	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-12-24	2024-12-27	25,000	$56.19	$1.40M	217,054	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2024-12-19	2024-12-20	1	—	$0	89,999	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2024-12-19	2024-12-20	9,880	—	$0	96,870	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2024-12-19	2024-12-20	9,880	$20.24	$200.0K	77,472	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2024-12-19	2024-12-20	1	$14.02	$14	77,473	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-12-03	2024-12-03	15,000	$67.00	$1.00M	242,054	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-11-25	2024-11-27	18,281	$51.43	$940.2K	263,773	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-11-25	2024-11-27	6,719	$52.04	$349.7K	257,054	SEC↗
CAPPS VICKIE L	Director	J Other	2024-11-05	2024-11-07	2,305	—	$0	70,348	SEC↗
Gujrathi Sheila	Director	J Other	2024-11-05	2024-11-07	4,611	—	$0	115,139	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-10-28	2024-10-30	11,103	$53.94	$598.9K	282,054	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-10-28	2024-10-30	13,897	$53.22	$739.6K	293,157	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	102,732	$50.30	$5.17M	2,629,085	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	19,900	$50.30	$1.00M	509,273	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	104,892	$50.30	$5.28M	2,684,380	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	15,462	$51.18	$791.3K	2,613,623	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	2,995	$51.18	$153.3K	506,278	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	15,788	$51.18	$808.0K	2,668,592	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	104,957	$44.75	$4.70M	401,321	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	553,219	$44.75	$24.76M	2,115,373	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-18	2024-10-18	541,824	$44.75	$24.25M	2,071,799	SEC↗
Kolchinsky Peter	Director, 10% Owner	P Buy	2024-10-18	2024-10-22	1,200,000	$44.75	$53.70M	9,317,246	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-17	2024-10-18	348	—	$0	9,142	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-17	2024-10-18	348	—	$0	9,142	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-17	2024-10-18	836	—	$0	21,940	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-17	2024-10-18	237	—	$0	6,072	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-17	2024-10-18	1,843	$50.02	$92.2K	6,371	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-17	2024-10-18	237	$39.80	$9.4K	8,214	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-17	2024-10-18	836	$17.00	$14.2K	7,281	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-17	2024-10-18	348	$10.73	$3.7K	7,629	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-17	2024-10-18	348	$13.22	$4.6K	7,977	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-16	2024-10-18	1,407	—	$0	6,309	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-16	2024-10-18	4,968	—	$0	22,776	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-16	2024-10-18	2,070	—	$0	9,490	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise deriv	2024-10-16	2024-10-18	2,070	—	$0	9,490	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-16	2024-10-18	60,179	$49.69	$2.99M	2,761,291	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-16	2024-10-18	11,657	$49.69	$579.2K	534,883	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-16	2024-10-18	61,445	$49.69	$3.05M	2,819,366	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-16	2024-10-18	29,474	$50.61	$1.49M	2,731,817	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-16	2024-10-18	5,710	$50.61	$289.0K	529,173	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-16	2024-10-18	30,094	$50.61	$1.52M	2,789,272	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-16	2024-10-18	4,968	$17.00	$84.5K	11,855	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-16	2024-10-18	2,070	$10.73	$22.2K	13,925	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-16	2024-10-18	2,070	$13.22	$27.4K	15,995	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	M Exercise	2024-10-16	2024-10-18	1,407	$39.80	$56.0K	17,402	SEC↗
Avalon BioVentures SPV I, L.P.	10% Owner	S Sale	2024-10-16	2024-10-18	10,957	$50.80	$556.6K	6,445	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-30	2024-09-30	434	—	$0	27,744	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-30	2024-09-30	181	—	$0	11,560	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-30	2024-09-30	181	—	$0	11,560	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-30	2024-09-30	123	—	$0	7,716	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-30	2024-09-30	434	$17.00	$7.4K	7,360	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-30	2024-09-30	181	$10.73	$1.9K	7,541	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-30	2024-09-30	181	$13.22	$2.4K	7,722	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-30	2024-09-30	123	$39.80	$4.9K	7,845	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-30	2024-09-30	958	$46.24	$44.3K	6,887	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise deriv	2024-09-27	2024-09-27	50,000	—	$0	100,667	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-27	2024-09-30	828	—	$0	28,178	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-27	2024-09-30	345	—	$0	11,741	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-27	2024-09-30	234	—	$0	7,839	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-27	2024-09-30	345	—	$0	11,741	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-09-27	2024-09-27	795	$47.84	$38.0K	307,054	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-09-27	2024-09-27	5,248	$46.86	$245.9K	307,849	SEC↗
Campbell David Alan	President and CEO	S Sale	2024-09-27	2024-09-27	18,957	$46.09	$873.7K	313,097	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	S Sale	2024-09-27	2024-09-27	675	$47.22	$31.9K	97,938	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	S Sale	2024-09-27	2024-09-27	4,325	$46.21	$199.9K	98,613	SEC↗
Meyer Andrew Hollman	Chief Business Officer	M Exercise	2024-09-27	2024-09-27	50,000	$4.21	$210.5K	117,592	SEC↗
Meyer Andrew Hollman	Chief Business Officer	S Sale	2024-09-27	2024-09-27	50,000	$45.96	$2.30M	67,592	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-27	2024-09-30	1,826	$46.19	$84.3K	6,926	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-27	2024-09-30	234	$39.80	$9.3K	8,752	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-27	2024-09-30	345	$13.22	$4.6K	8,518	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-27	2024-09-30	345	$10.73	$3.7K	8,173	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-27	2024-09-30	828	$17.00	$14.1K	7,828	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-27	2024-09-30	1,542	$47.74	$73.6K	2,880,811	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-27	2024-09-30	293	$47.74	$14.0K	546,540	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-27	2024-09-30	1,511	$47.74	$72.1K	2,821,470	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-27	2024-09-30	46,861	$46.42	$2.18M	2,882,353	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-27	2024-09-30	45,894	$46.42	$2.13M	2,822,981	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-27	2024-09-30	8,894	$46.42	$412.9K	546,833	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-26	2024-09-30	41,661	$47.77	$1.99M	2,929,214	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-26	2024-09-30	7,908	$47.77	$377.8K	555,727	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-26	2024-09-30	40,803	$47.77	$1.95M	2,868,875	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-26	2024-09-30	50,539	$46.78	$2.36M	2,970,875	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-26	2024-09-30	9,592	$46.78	$448.7K	563,635	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-26	2024-09-30	49,497	$46.78	$2.32M	2,909,678	SEC↗
Lichter Jay	10% Owner	M Exercise deriv	2024-09-13	2024-10-24	391	—	$0	7,682	SEC↗
Lichter Jay	10% Owner	M Exercise deriv	2024-09-13	2024-10-24	778	—	$0	11,308	SEC↗
Lichter Jay	10% Owner	M Exercise deriv	2024-09-13	2024-10-24	778	—	$0	11,308	SEC↗
Lichter Jay	10% Owner	M Exercise deriv	2024-09-13	2024-10-24	1,868	—	$0	27,138	SEC↗
Lichter Jay	10% Owner	S Sale	2024-09-13	2024-10-24	3,815	$46.68	$178.1K	7,000	SEC↗
Lichter Jay	10% Owner	M Exercise	2024-09-13	2024-10-24	1,868	$17.00	$31.8K	8,868	SEC↗
Lichter Jay	10% Owner	M Exercise	2024-09-13	2024-10-24	778	$10.73	$8.3K	9,646	SEC↗
Lichter Jay	10% Owner	M Exercise	2024-09-13	2024-10-24	778	$13.22	$10.3K	10,424	SEC↗
Lichter Jay	10% Owner	M Exercise	2024-09-13	2024-10-24	391	$39.80	$15.6K	10,815	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-12	2024-09-12	158,031	$47.00	$7.43M	2,959,175	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-12	2024-09-12	161,356	$47.00	$7.58M	3,021,414	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-12	2024-09-12	30,613	$47.00	$1.44M	573,227	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-10	2024-09-12	35,047	$46.66	$1.64M	3,182,770	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-10	2024-09-12	6,649	$46.66	$310.2K	603,840	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-10	2024-09-12	34,326	$46.66	$1.60M	3,117,206	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-10	2024-09-12	11,557	$46.13	$533.1K	3,217,817	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-10	2024-09-12	2,193	$46.13	$101.2K	610,489	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-10	2024-09-12	11,319	$46.13	$522.1K	3,151,532	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-09	2024-09-10	414	—	$0	12,086	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-09	2024-09-10	414	—	$0	12,086	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-09	2024-09-10	994	—	$0	29,006	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise deriv	2024-09-09	2024-09-10	277	—	$0	8,073	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-09	2024-09-10	994	$17.00	$16.9K	8,077	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-09	2024-09-10	414	$10.73	$4.4K	8,491	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-09	2024-09-10	277	$39.80	$11.0K	9,182	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-09	2024-09-10	2,182	$42.33	$92.4K	7,000	SEC↗
Avalon BioVentures I, LP	10% Owner	M Exercise	2024-09-09	2024-09-10	414	$13.22	$5.5K	8,905	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-06	2024-09-10	110,644	$42.00	$4.65M	3,229,374	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-06	2024-09-10	20,991	$42.00	$881.6K	612,682	SEC↗
Avalon BioVentures I, LP	10% Owner	S Sale	2024-09-06	2024-09-10	108,365	$42.00	$4.55M	3,162,851	SEC↗
Hernday Natasha	Director	A Award deriv	2024-07-19	2024-07-22	16,700	—	$0	16,700	SEC↗
Hernday Natasha	Director	A Award deriv	2024-07-19	2024-07-22	8,350	—	$0	8,350	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2024-07-19	2024-07-22	8,350	—	$0	8,350	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2024-07-19	2024-07-22	16,700	—	$0	16,700	SEC↗
Hernday Natasha	Director	A Award deriv	2024-07-19	2024-07-24	4,111	—	$0	4,111	SEC↗
DOBMEIER ERIC	Director	A Award deriv	2024-07-19	2024-07-24	4,111	—	$0	4,111	SEC↗
Hernday Natasha	Director	A Award	2024-07-19	2024-07-22	2,500	—	$0	7,500	SEC↗
Hernday Natasha	Director	A Award	2024-07-19	2024-07-22	5,000	—	$0	5,000	SEC↗
DOBMEIER ERIC	Director	A Award	2024-07-19	2024-07-22	2,500	—	$0	7,500	SEC↗
DOBMEIER ERIC	Director	A Award	2024-07-19	2024-07-22	5,000	—	$0	5,000	SEC↗
Hernday Natasha	Director	A Award	2024-07-19	2024-07-24	1,231	—	$0	6,231	SEC↗
DOBMEIER ERIC	Director	A Award	2024-07-19	2024-07-24	1,231	—	$0	6,231	SEC↗
CAPPS VICKIE L	Director	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
Simson Jake	Director	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
Barrett Ronald W	Director	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
Gujrathi Sheila	Director	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
Kung Winston	Director	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
McNulty Alana B.	Director	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
Lichter Jay	Director, 10% Owner	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
RA CAPITAL MANAGEMENT, L.P.	Director, 10% Owner	A Award deriv	2024-06-26	2024-06-28	8,350	—	$0	8,350	SEC↗
CAPPS VICKIE L	Director	A Award	2024-06-26	2024-06-28	2,500	—	$0	68,043	SEC↗
Simson Jake	Director	A Award	2024-06-26	2024-06-28	2,500	—	$0	2,500	SEC↗
Barrett Ronald W	Director	A Award	2024-06-26	2024-06-28	2,500	—	$0	2,500	SEC↗
Gujrathi Sheila	Director	A Award	2024-06-26	2024-06-28	2,500	—	$0	110,528	SEC↗
Kung Winston	Director	A Award	2024-06-26	2024-06-28	2,500	—	$0	2,500	SEC↗
McNulty Alana B.	Director	A Award	2024-06-26	2024-06-28	2,500	—	$0	2,500	SEC↗
Lichter Jay	Director, 10% Owner	A Award	2024-06-26	2024-06-28	2,500	—	$0	7,083	SEC↗
RA CAPITAL MANAGEMENT, L.P.	Director, 10% Owner	A Award	2024-06-26	2024-06-28	2,500	—	$0	2,500	SEC↗
Avalon Ventures XI, L.P.	10% Owner	S Sale	2024-06-03	2024-06-05	677,279	$54.75	$37.08M	3,271,216	SEC↗
Avalon Ventures XI, L.P.	10% Owner	S Sale	2024-06-03	2024-06-05	691,525	$54.75	$37.86M	3,340,018	SEC↗
Avalon Ventures XI, L.P.	10% Owner	S Sale	2024-06-03	2024-06-05	131,196	$54.75	$7.18M	633,673	SEC↗
Reardon Tighe	Acting Chief Financial Offic	S Sale	2024-06-03	2024-06-05	131,196	$54.75	$7.18M	633,673	SEC↗
Reardon Tighe	Acting Chief Financial Offic	S Sale	2024-06-03	2024-06-05	691,525	$54.75	$37.86M	3,340,018	SEC↗
Lichter Jay	Director, 10% Owner	S Sale	2024-06-03	2024-06-05	691,525	$54.75	$37.86M	3,340,018	SEC↗
Lichter Jay	Director, 10% Owner	S Sale	2024-06-03	2024-06-05	131,196	$54.75	$7.18M	633,673	SEC↗
Lichter Jay	Director, 10% Owner	S Sale	2024-06-03	2024-06-05	677,279	$54.75	$37.08M	3,271,216	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy deriv	2024-03-04	2024-03-06	1,397,849	$46.50	$65.00M	1,397,849	SEC↗
CAPPS VICKIE L	Director	J Other	2024-02-29	2024-03-04	1,493	—	$0	65,543	SEC↗
Gujrathi Sheila	Director	J Other	2024-02-29	2024-03-04	2,986	—	$0	108,028	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	447,949	—	$0	4,031,543	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	11,388	—	$0	0	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	11,388	—	$0	11,388	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	31,456	—	$0	31,456	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	31,456	—	$0	0	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	84,985	—	$0	764,869	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	1,700	—	$0	1,700	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	1,700	—	$0	0	SEC↗
Avalon Ventures XI, L.P.	10% Owner	J Other	2024-02-29	2024-03-04	438,722	—	$0	3,948,495	SEC↗
DiRaimondo Thomas	Chief Scientific Officer	A Award deriv	2024-01-02	2024-01-03	147,000	—	$0	147,000	SEC↗
Campbell David Alan	President and CEO	A Award deriv	2024-01-02	2024-01-03	356,500	—	$0	356,500	SEC↗
Meyer Andrew Hollman	Chief Business Officer	A Award deriv	2024-01-02	2024-01-03	105,000	—	$0	105,000	SEC↗
Reardon Tighe	Acting Chief Financial Offic	A Award deriv	2024-01-02	2024-01-03	157,000	—	$0	157,000	SEC↗
Robinson Byron	Chief Strategy Officer	A Award deriv	2024-01-02	2024-01-03	151,500	—	$0	151,500	SEC↗
Winter Charles M.	Chief Technical Officer	A Award deriv	2024-01-02	2024-01-03	111,000	—	$0	111,000	SEC↗
Avalon Ventures XI, L.P.	10% Owner	P Buy	2023-11-13	2023-11-13	849,854	$5.87	$4.99M	849,854	SEC↗
Lichter Jay	Director, 10% Owner	P Buy	2023-11-13	2023-11-15	849,854	$5.87	$4.99M	849,854	SEC↗
Reardon Tighe	Acting Chief Financial Offic	P Buy	2023-11-13	2023-11-15	849,854	$5.87	$4.99M	849,854	SEC↗
RA Capital Nexus Fund II, L.P.	Director	P Buy deriv	2023-07-19	2023-07-21	503,226	$12.46	$6.27M	503,226	SEC↗
RA Capital Nexus Fund II, L.P.	Director	P Buy	2023-07-19	2023-07-21	495,008	$12.46	$6.17M	8,117,246	SEC↗
Barrett Ronald W	Director	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
CAPPS VICKIE L	Director	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
Gujrathi Sheila	Director	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
Kung Winston	Director	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
Simson Jake	Director	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
McNulty Alana B.	Director	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
Lichter Jay	Director, 10% Owner	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
RA Capital Nexus Fund II, L.P.	Director	A Award deriv	2023-06-14	2023-06-16	12,500	—	$0	12,500	SEC↗
Campbell David Alan	Chief Executive Officer	A Award deriv	2023-01-03	2023-01-05	310,000	—	$0	310,000	SEC↗
Godfrey Wayne	Chief Medical Officer	A Award deriv	2023-01-03	2023-01-05	110,000	—	$0	110,000	SEC↗
Meyer Andrew Hollman	Chief Business Officer	A Award deriv	2023-01-03	2023-01-05	90,000	—	$0	90,000	SEC↗
Reardon Tighe	Acting Chief Financial Offic	A Award deriv	2023-01-03	2023-01-05	110,000	—	$0	110,000	SEC↗
Robinson Byron	Chief Strategy Officer	A Award deriv	2023-01-03	2023-01-05	100,000	—	$0	100,000	SEC↗
Winter Charles M.	Chief Technical Officer	A Award deriv	2023-01-03	2023-01-05	100,000	—	$0	100,000	SEC↗
Kung Winston	Director	A Award deriv	2022-09-21	2022-09-22	9,375	—	$0	9,375	SEC↗